UniSuper Management’s Eli Lilly LLY Stock Holding History

UniSuper Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$144M	Sell	156,372 -7,989	-5%	-$8.1M	0.94%	18
2025 Q4	$177M	Sell	164,361 -426	-0.3%	-$407K	1.06%	16
2025 Q3	$126M	Buy	164,787 +19,987	+14%	+$14.9M	0.77%	19
2025 Q2	$113M	Sell	144,800 -16,864	-10%	-$13.1M	0.76%	19
2025 Q1	$134M	Buy	161,664 +16,982	+12%	+$14.1M	1%	17
2024 Q4	$112M	Sell	144,682 -5,364	-4%	-$4.44M	0.8%	20
2024 Q3	$133M	Buy	150,046 +28,526	+23%	+$25.6M	1%	17
2024 Q2	$110M	Buy	121,520 +45,738	+60%	+$36.6M	0.91%	21
2024 Q1	$59M	Buy	75,782 +41,456	+121%	+$29.5M	0.56%	42
2023 Q4	$20M	Sell	34,326 -6,051	-15%	-$3.53M	0.22%	96
2023 Q3	$21.7M	Buy	40,377 +26,930	+200%	+$13.9M	0.27%	88
2023 Q2	$6.31M	Buy	+13,447	New	+$5.64M	0.07%	164

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UniSuper Management's LLY Position: Q1 2026 in Review

UniSuper Management reduced its Eli Lilly (LLY) stake by 4.9% in Q1 2026, selling an estimated $8.1M and leaving 156,372 shares worth $144M. The position accounts for 0.94% of the portfolio, ranked #18.

UniSuper Management first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $177M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

UniSuper Management held 156,372 shares of Eli Lilly worth $144M as of Q1 2026.
UniSuper Management sold 7,989 Eli Lilly shares in Q1 2026, an estimated $8.1M.
Eli Lilly made up 0.94% of UniSuper Management's portfolio in Q1 2026, its #18 holding.
UniSuper Management first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
UniSuper Management's Eli Lilly position peaked at $177M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on UniSuper Management's 13F filing for Q1 2026, filed 11 May 2026.